The U.S. Supreme Court on Monday turned away Pfizer Inc.’s bid to revive its plan to cover out-of-pocket expenses of Medicare patients for drugs costing $225,000 a year to treat a rare heart condition after federal officials found that the drugmaker’s arrangement could amount to illegal kickbacks.
A reanalysis of data from the FOURIER trial found a higher risk of cardiovascular death associated with Amgen’s injectable cholesterol therapeutic Repatha (evolocumab), according to a study published last month.
Yesterday the Supreme Court turned down Novartis’ bid to block the launch of generic versions of the company’s blockbuster multiple sclerosis drug Gilenya in a dispute with China’s HEC Pharm Co Ltd and other generic drugmakers.
Biden, doctors say new abortion laws have chilling impact By Nandita Bose WASHINGTON, Oct 4 (Reuters) – U.S. President Joe Biden and top White House officials announced new guidelines and grants to protect abortion and contraception rights on Tuesday, and said women’s rights have already been curtailed since the Supreme Court overturned Roe vs. Wade […]
The U.S. Supreme Court on Monday declined to hear a challenge by Missouri and nine other states – mostly Republican-led – to President Joe Biden’s COVID-19 vaccine mandate for workers in healthcare facilities that receive federal funds.
The U.S. Supreme Court on Monday declined to hear Biogen Inc’s (BIIB.O) bid to win reinstatement of a patent on the company’s blockbuster multiple sclerosis drug Tecfidera in a dispute with Viatris Inc. subsidiary (VTRS.O) Mylan Pharmaceuticals Inc.
A 3-judge panel questioned the legitimacy of Johnson & Johnson’s plan to form a subsidiary company with the purpose of absorbing legal liabilities from talc-related lawsuits.
U.S. Supreme Court Justice Sonia Sotomayor on Monday declined to block New York City from enforcing its mandate that all municipal workers be vaccinated against COVID-19, rebuffing a police detective who challenged the public health policy.
With West Virginia’s 1849 abortion ban tied up in court and its conservative legislature stymied over details of enacting a new one, the state’s only abortion clinic ought to be operating as usual.
A manufacturer of the drug used in medication abortions on Thursday dropped its bid to sell mifepristone in Mississippi despite the state’s recently enacted abortion ban.